The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
You look at the hazard ratios for mortality when you're talking about obesity. You're not talking about like if we're talking about like um like class three, class four obesity, even with healthy blood markers, healthy obesity, you're not talking about 20 30%. You're talking about 80 to 200%.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
When you're talking about things like obesity. You're not talking about like if we're talking about like um like class three, class four obesity, even with healthy blood markers, healthy obesity, you're not talking about 20 30%. You're talking about 80 to 200%. You're talking about massive increases in the risk of mortality.